申请人:Zeneca Limited
公开号:US05521179A1
公开(公告)日:1996-05-28
The present invention relates to certain novel heterocyclic amides which are 1-pyridylacetamide compounds of formula I, set out herein, which are inhibitors of human leukocyte elastase (HLE), also known as human neutrophil elastase (HNE), making them useful whenever such inhibition is desired, such as for research tools in pharmacological, diagnostic and related studies and in the treatment of diseases in mammals in which HLE is implicated. The invention also includes intermediates useful in the synthesis of these heterocyclic amides, processes for preparing the heterocyclic amides, pharmaceutical compositions containing such heterocyclic amides and methods for their use.
本发明涉及某些新颖的杂环酰胺,它们是式I所示的1-吡啶乙酰胺化合物,这些化合物是人类白细胞弹性蛋白酶(HLE)的抑制剂,也被称为人类中性粒细胞弹性蛋白酶(HNE),使它们在需要这种抑制作用时非常有用,例如用作药理学、诊断和相关研究工具以及治疗哺乳动物中HLE相关疾病。该发明还包括在合成这些杂环酰胺过程中有用的中间体,制备这些杂环酰胺的方法,含有这些杂环酰胺的药物组合物以及它们的使用方法。